CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

WuXi Biologics Wins Two Grand Awards at 2026 Hong Kong ESG Reporting Awards

By Public Technologies
  • WuXi Biologics won two Grand Awards at the 2026 Hong Kong ESG Reporting Awards for ESG reporting and environmental impact.
  • The honors covered Best ESG Report (Large-Cap) and Excellence in Environmental Positive Impact.
  • Selected from 120 entries, it was the only pharmaceutical company to receive a Grand Award.
  • In 2025, the Science Based Targets initiative validated its near-term, long-term and net-zero emissions reduction targets.
  • The targets cover Scope 1, 2 and 3 emissions, aligned with a 1.5°C pathway.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk